Robotic vs open: which whipple surgery is safer for pancreatic cancer?

NCT ID NCT04763642

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared miniinvasive (robotic or laparoscopic) Whipple surgery to the traditional open approach in 320 patients with pancreatic, bile duct, or ampulla of Vater cancers. The goal was to see which method leads to fewer complications like pancreatic leaks, bleeding, or infections. Results could help guide surgical choices for these cancers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Whipple surgery (robotic, laparoscopic, or open)
What this could lead to
If successful, this could show that less invasive surgery is as safe and effective as open surgery, with possibly shorter hospital stays and fewer complications.
What could go wrong
This is a completed study comparing surgical techniques, not a new drug or cure. Results may not apply to all patients or hospitals, and surgery always carries risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMPULLA OF VATER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ochapovsky Regional Clinical Hospital № 1

    Krasnodar, Krasnodarskiy Kray, 350068, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.